Downstream bioprocessing of human pluripotent stem cell-derived therapeutics.

Sart S, Liu C, Zeng EZ, Xu C, Li Y

DOI: 10.1002/elsc.202100042
Published: 2022 Nov
Container: Engineering in life sciences
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1002/elsc.202100042,
  title = {Downstream bioprocessing of human pluripotent stem cell-derived therapeutics.},
  author = {Sart S and Liu C and Zeng EZ and Xu C and Li Y},
  year = {2022},
  journal = {Engineering in life sciences},
  doi = {10.1002/elsc.202100042},
  url = {https://doi.org/10.1002/elsc.202100042}
}

RIS

TY  - JOUR
TI  - Downstream bioprocessing of human pluripotent stem cell-derived therapeutics.
AU  - Sart S
AU  - Liu C
AU  - Zeng EZ
AU  - Xu C
AU  - Li Y
PY  - 2022
JO  - Engineering in life sciences
DO  - 10.1002/elsc.202100042
UR  - https://doi.org/10.1002/elsc.202100042
ER  -

APA

S, S., C, L., EZ, Z., C, X., & Y, L. (2022). Downstream bioprocessing of human pluripotent stem cell-derived therapeutics.. Engineering in life sciences. https://doi.org/10.1002/elsc.202100042

Source records

pubmed · retrieved 2026-09-25T07:44:35.221Z